| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1623 | 2015 |
| CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1454 | 2009 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1336 | 2022 |
| The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment GA Carlesimo, C Caltagirone, G Gainotti, L Fadda, R Gallassi, S Lorusso, ... European neurology 36 (6), 378-384, 1996 | 1262 | 1996 |
| Neurofilament light chain as a biomarker in neurological disorders L Gaetani, K Blennow, P Calabresi, M Di Filippo, L Parnetti, H Zetterberg Journal of Neurology, Neurosurgery & Psychiatry 90 (8), 870-881, 2019 | 1002 | 2019 |
| CSF and blood biomarkers for Parkinson's disease L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ... The Lancet Neurology 18 (6), 573-586, 2019 | 555 | 2019 |
| A practical guide to immunoassay method validation U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ... Frontiers in neurology 6, 179, 2015 | 517 | 2015 |
| Dysphagia following stroke M Paciaroni, G Mazzotta, F Corea, V Caso, M Venti, P Milia, G Silvestrelli, ... European neurology 51 (3), 162-167, 2004 | 445 | 2004 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 438 | 2011 |
| A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance P Calabresi, B Picconi, L Parnetti, M Di Filippo The Lancet Neurology 5 (11), 974-983, 2006 | 422 | 2006 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 405 | 2013 |
| Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers … H Vanderstichele, M Bibl, S Engelborghs, N Le Bastard, P Lewczuk, ... Alzheimer's & Dementia 8 (1), 65-73, 2012 | 380 | 2012 |
| Consensus guidelines for lumbar puncture in patients with neurological diseases S Engelborghs, E Niemantsverdriet, H Struyfs, K Blennow, R Brouns, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 111-126, 2017 | 350 | 2017 |
| Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ... Biomarkers in medicine 6 (4), 419-430, 2012 | 349 | 2012 |
| A multicentre validation study of the diagnostic value of plasma neurofilament light NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ... Nature communications 12 (1), 3400, 2021 | 347 | 2021 |
| Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease TE Moors, JJM Hoozemans, A Ingrassia, T Beccari, L Parnetti, ... Molecular neurodegeneration 12, 1-18, 2017 | 324 | 2017 |
| The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean? FH Duits, CE Teunissen, FH Bouwman, PJ Visser, N Mattsson, ... Alzheimer's & Dementia 10 (6), 713-723. e2, 2014 | 323 | 2014 |
| Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease P Lewczuk, A Matzen, K Blennow, L Parnetti, JL Molinuevo, P Eusebi, ... Journal of Alzheimer’s Disease 55 (2), 813-822, 2016 | 276 | 2016 |
| Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data L Parnetti, F Amenta, V Gallai Mechanisms of ageing and development 122 (16), 2041-2055, 2001 | 275 | 2001 |
| Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease L Parnetti, D Chiasserini, E Persichetti, P Eusebi, S Varghese, ... Movement Disorders 29 (8), 1019-1027, 2014 | 267 | 2014 |
